Oxford Health NHS Foundation Trust
Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Formulary Chapter 17: COVID-19 - useful medicines information -
Full Section
Useful Links
ACEIs & ARBs: ACE-Inhibitors / Angiotensin Receptor Blockers and coronavirus - Position Statement from the European Society of Cardiology Council on Hypertension
AGITATED BEHAVIOUR: Managing acutely disturbed behaviour in the context of COVID-19: National Association of Psychiatric Intensive Care & Low Secure Units
ANTIPSYCHOTIC LAIs: Guidance on amending the dosing interval of antipsychotic long-acting injections (LAIs)
CHLOROQUINE and HYDROXYCHLOROQUINE: MHRA statement
CLOZAPINE: Coronavirus (COVID-19) and clozapine - information for Healthcare Professionals VERSION 3
CLOZAPINE: DMS off-label clozapine form
CLOZAPINE: Information for patients: Clozapine, blood testing and the coronavirus/COVID-19 outbreak
CONTROLLED DRUGS: CD reconciliation policy during COVID-19 outbreak - reduced frequency
CORTICOSTEROIDS: including dexamethasone and hydrocortisone - COVID-19 therapy guidance from NHS England
DELIRIUM: Delirium management and COVID-19 (coronavirus)
END OF LIFE CARE: Oxfordshire Guidelines for End of Life Symptom Management during the coronavirus outbreak (COVID-19)
GENERAL: COVID-19 guidance and information for different medicines and medical specialties (from Specialist Pharmacy Service)
LITHIUM: Lithium monitoring and COVID-19 VERSION 2
MEDICAL SPECIALITIES: Links by specialty to national COVID-19 guidance related to medicines
NICE: COVID-19 guidance from NICE
NSAIDS: Coronavirus and anti-inflammatories - NHS Medical Director updated advice to clinical staff April 14th
OLANZAPINE LONG ACTING INJECTION (OLAI): Guidance for managing the 3 hours of monitoring during the coronavirus (COVID19) outbreak
OXYGEN: BOC medical oxygen supply plans during coronavirus (COVID-19) outbreak
OXYGEN: Increased demand on medical oxygen supply systems - management of ice build up
REMOTE PRESCRIBING: Guidance to clinicians who are prescribing remotely to outpatients VERSION 2
REMOTE PRESCRIBING: Inpatient PRN chart
REMOTE PRESCRIBING: NRT inpatient PRN prescription
REMOTE PRESCRIBING: PRN paracetamol inpatient chart
RETURN OF MEDICATION: Guidance about the return of medicines to Pharmacy and disposal of medicines during COVID-19 (version2)
SMOKING CESSATION: Enforced abstinence protocol (updated for coronavirus outbreak)
SMOKING CESSATION: The effects on psychotropic medication
VACCINATION: COVID-19 the Green Book provisional guidance
VACCINE - Pfizer-BioNTech COVID-19 vaccine summary of guidance for Healthcare Professionals from SPS
VACCINE PROGRAMME - Public Health England Resources
VACCINE update: COVID-19 vaccination programme special edition Dec 2020
VALPROATE: Temporary MHRA guidance for managing the Pregnancy Prevention Programme during the pandemic
VITAMIN D: A rapid review of the evidence for treatment or prevention in COVID-19 [CEBM]
VTE PREVENTION: Interim OUHFT thromboprophylaxis guidance for patients with suspected or proven COVID-19
WARD POLICY: Non-pharmacy dispensing of medication (TTOs) extended from 3 days to 14 days during COVID-19 outbreak
WARFARIN and other anticoagulants: MHRA guidance on monitoring during the COVID pandemic October 2020
WARFARIN: Guidance on safe switching from warfarin to Direct Oral Anticoagulants (DOACs) for patients with non-valvular AFand venous thromboembolism (DVT/ PE) during coronavirus pandemic
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
17
(0,0)